Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram in progressive fibrosing interstitial lung disease
jRCTs031220648Recruiting
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of disulfiram in progressive pulmonary fibrosis (PPF). Primary endpoint: Frequency of Grade 2 or higher adverse events. Started Feb 2024; status: recruiting.
02
Drugs
disulfiram
03
Conditions
progressive pulmonary fibrosis (PPF)
Beyond the preview
Go deeper on jRCTs031220648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220648.